Pure Health Holding PJSC Statistics

Total Valuation

ADX:PUREHEALTH has a market cap or net worth of AED 30.11 billion. The enterprise value is 32.28 billion.

Market Cap	30.11B
Enterprise Value	32.28B

Important Dates

The next estimated earnings date is Thursday, May 1, 2025.

Earnings Date	May 1, 2025
Ex-Dividend Date	Apr 18, 2025

Share Statistics

ADX:PUREHEALTH has 11.11 billion shares outstanding. The number of shares has increased by 10.71% in one year.

Current Share Class	n/a
Shares Outstanding	11.11B
Shares Change (YoY)	+10.71%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.12%
Float	2.24B

Valuation Ratios

The trailing PE ratio is 17.59 and the forward PE ratio is 12.68.

PE Ratio	17.59
Forward PE	12.68
PS Ratio	1.16
PB Ratio	1.53
P/TBV Ratio	2.72
P/FCF Ratio	8.89
P/OCF Ratio	7.23
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.86, with an EV/FCF ratio of 9.53.

EV / Earnings	18.86
EV / Sales	1.25
EV / EBITDA	7.86
EV / EBIT	12.37
EV / FCF	9.53

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.73.

Current Ratio	1.88
Quick Ratio	1.66
Debt / Equity	0.73
Debt / EBITDA	3.50
Debt / FCF	4.24
Interest Coverage	3.16

Financial Efficiency

Return on equity (ROE) is 9.59% and return on invested capital (ROIC) is 6.26%.

Return on Equity (ROE)	9.59%
Return on Assets (ROA)	4.25%
Return on Invested Capital (ROIC)	6.26%
Return on Capital Employed (ROCE)	7.15%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.67
Inventory Turnover	19.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	3.00
200-Day Moving Average	3.45
Relative Strength Index (RSI)	43.50
Average Volume (20 Days)	6,465,506

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ADX:PUREHEALTH had revenue of AED 25.85 billion and earned 1.71 billion in profits. Earnings per share was 0.15.

Revenue	25.85B
Gross Profit	6.64B
Operating Income	2.61B
Pretax Income	1.78B
Net Income	1.71B
EBITDA	3.48B
EBIT	2.61B
Earnings Per Share (EPS)	0.15

Full Income Statement

Balance Sheet

The company has 12.22 billion in cash and 14.37 billion in debt, giving a net cash position of -2.15 billion or -0.19 per share.

Cash & Cash Equivalents	12.22B
Total Debt	14.37B
Net Cash	-2.15B
Net Cash Per Share	-0.19
Equity (Book Value)	19.74B
Book Value Per Share	1.77
Working Capital	10.65B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.16 billion and capital expenditures -777.53 million, giving a free cash flow of 3.39 billion.

Operating Cash Flow	4.16B
Capital Expenditures	-777.53M
Free Cash Flow	3.39B
FCF Per Share	0.30

Full Cash Flow Statement

Margins

Gross margin is 25.67%, with operating and profit margins of 10.10% and 6.62%.

Gross Margin	25.67%
Operating Margin	10.10%
Pretax Margin	6.88%
Profit Margin	6.62%
EBITDA Margin	13.47%
EBIT Margin	10.10%
FCF Margin	13.10%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 1.14%.

Dividend Per Share	0.03
Dividend Yield	1.14%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.71%
Shareholder Yield	-9.57%
Earnings Yield	5.68%
FCF Yield	11.24%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ADX:PUREHEALTH has an Altman Z-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2
Piotroski F-Score	n/a